Table 4.

Adjusted mean doses of warfarin prescribed according to different genotype/haplotype




Adjusted mean, mg

95% CI

Significance
VKORC1    
    1173CC   6.2   5.0-7.3   Ref  
    1173CT   4.8   3.8-5.9   .002  
    1173TT   3.5   2.2-4.8   < .001  
    .018* 
CYP2C9    
    CYP2C9*1   6.0   5.3-6.7   Ref  
    CYP2C9*2   4.7   3.8-5.5   .002  
    CYP2C9*3   3.8   2.7-4.8   < .001  
    CYP2C9*2 + CYP2C9*3
 
4.9
 
1.6-8.3
 
NS
 



Adjusted mean, mg

95% CI

Significance
VKORC1    
    1173CC   6.2   5.0-7.3   Ref  
    1173CT   4.8   3.8-5.9   .002  
    1173TT   3.5   2.2-4.8   < .001  
    .018* 
CYP2C9    
    CYP2C9*1   6.0   5.3-6.7   Ref  
    CYP2C9*2   4.7   3.8-5.5   .002  
    CYP2C9*3   3.8   2.7-4.8   < .001  
    CYP2C9*2 + CYP2C9*3
 
4.9
 
1.6-8.3
 
NS
 

Adjusted mean is calculated as the mean daily dose of warfarin taking into account other variables.

CI indicates confidence intervals; Ref, reference group, NS, not significant.

*

Versus CT genotype.

Close Modal

or Create an Account

Close Modal
Close Modal